Trial intelligence / Profile preview

Effect of fibrin glue on postoperative air leak after thoracic surgery

IRCT20190408043196N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Apr 2020
Modality
Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 3, open-label trial of tachosil in air-leak syndrome, empyema and None (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Improvement of postoperative air leak. Started Apr 2020; status: completed.

02

Drugs

tachosil
03

Conditions

air-leak syndromeempyema

Beyond the preview

Go deeper on IRCT20190408043196N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190408043196N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call